MALVERN, PA, USA I June 10, 2024 I Almirall, a global pharmaceutical company dedicated to medical dermatology, announced ...

THE question that comes up for me again and again when I read the story of Blessed Carlo Acutis is: “How did he know?” How ...

WESTLAKE VILLAGE, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today ...

A Delta County business owner with experience in construction, real estate and health care, Curtis McCrackin pitches himself ...

Complicated Urinary Tract Infections Treatment Market is projected to reach USD 16.1 billion by 2033, trailing a CAGR of 5.76 ...

New long-term safety and efficacy data of investigational roflumilast cream 0.15% in mild to moderate atopic dermatitis will be presented in an oral sessionPreclinical data on ARQ-234, CD200R agonist, ...

Let's hope this new mission turns into a long-term story. The post General Hospital Spoilers: A New Mission Looms for Portia ...

Three years ago, Kennette started rehabbing homes. She survived by her children, Ka’ Monya Dabney and Colerion Franklin; parents, Ellener (Cutis) Hughes and Kenneth Dabney Sr.; siblings, Thalamus ...

Mizuho raised the price target for the Arcutis Biotherapeutics Inc (NASDAQ:ARQT) stock from “a Neutral” to “a Buy”. The rating was released on January 03, 2024, according to finviz. We previously ...

CLINTON ― Pope Francis has paved the way to canonize the first millennial saint, Carlo Acutis, and an exhibit dedicated to ...

Analyst Uy Ear of Mizuho Securities reiterated a Buy rating on Arcutis Biotherapeutics (ARQT – Research Report), retaining the price target of $18.00. Uy Ear has given his Buy rating due to a ...

Mizuho raised the price target for the Arcutis Biotherapeutics Inc (NASDAQ:ARQT) stock from “a Neutral” to “a Buy”. The rating was released on January 03, 2024, according to finviz. We previously ...